Gene · 1326
Papers2,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical, Morphological and Molecular Features of Spitz tumors. | Cesk Patol | 2024 | 38697826 | PubTator, text mining | PubMed |
| Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature. | Sci Rep | 2024 | 38688945 | PubTator, text mining | PubMed |
| CoT: a transformer-based method for inferring tumor clonal copy number substructure from scDNA-seq data. | Brief Bioinform | 2024 | 38670159 | PubTator, text mining | PubMed |
| Kinase Fusions in Spitz Melanocytic Tumors: The Past, the Present, and the Future. | Dermatopathology (Basel) | 2024 | 38390852 | PubTator, text mining | PubMed |
| VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. | Nat Commun | 2024 | 38291039 | PubTator, text mining | PubMed |
| Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. | Cancers (Basel) | 2024 | 38275910 | PubTator, text mining | PubMed |
| A fully automated deep learning approach for coronary artery segmentation and comprehensive characterization. | APL Bioeng | 2024 | 38269204 | PubTator, text mining | PubMed |
| Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development. | Viruses | 2024 | 38257828 | PubTator, text mining | PubMed |
| Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature. | Dermatopathology (Basel) | 2024 | 38247727 | PubTator, text mining | PubMed |
| Clinical, Morphologic, and Molecular Features of MAP3K8 Rearranged Spitz Neoplasms: A Retrospective Study Documenting That Bonafide Spitz Melanomas Are Rare. | Am J Surg Pathol | 2024 | 38233731 | PubTator, text mining | PubMed |
| Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis. | PLoS One | 2024 | 38227591 | PubTator, text mining | PubMed |
| Latest Progress of LIPUS in Fracture Healing: A Mini-Review. | J Ultrasound Med | 2024 | 38224522 | PubTator, text mining | PubMed |
| Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression. | Cancer Cell Int | 2024 | 38185635 | PubTator, text mining | PubMed |
| Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer. | BMC Cancer | 2024 | 38166764 | PubTator, text mining | PubMed |
| A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. | Obstet Gynecol Sci | 2024 | 38050353 | PubTator, text mining | PubMed |
| Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features. | J Cutan Pathol | 2024 | 38031352 | PubTator, text mining | PubMed |
| Leishmania surface molecule lipophosphoglycan-TLR2 interaction moderates TPL2-mediated TLR2 signalling for parasite survival. | Immunology | 2024 | 37849037 | PubTator, text mining | PubMed |
| Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer. | Environ Toxicol | 2024 | 37647346 | PubTator, text mining | PubMed |
| An updated literature on BRAF inhibitors (2018-2023). | Mol Divers | 2024 | 37470921 | PubTator, text mining | PubMed |
| TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma. | medRxiv | 2024 | 37398275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1326/papers?page=5